LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 58

Search options

  1. Article: Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.

    Cevher, Erdal / Orhan, Zafer / Sensoy, Demet / Ahiskali, Rengin / Kan, Pei Lee / Sağirli, Olcay / Mülazimoğlu, Lütfiye

    Journal of microencapsulation

    2007  Volume 24, Issue 6, Page(s) 577–595

    Abstract: Purpose: The aim of this study was to prepare poly(D,L-lactide-co-glycolide) (PLGA) microspheres ...

    Abstract Purpose: The aim of this study was to prepare poly(D,L-lactide-co-glycolide) (PLGA) microspheres containing sodium fusidate (SF) using a double emulsion solvent evaporation method with varying polymer:drug ratios (1:1, 2.5:1, 5:1) and to evaluate its efficiency for the local treatment of chronic osteomyelitis.
    Methods: The particle size and distribution, morphological characteristics, thermal behaviour, drug content, encapsulation efficiency and in vitro release assessments of the formulations had been carried out. Sterilized SF-PLGA microspheres were implanted in the proximal tibia of rats with methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. After 3 weeks of treatment, bone samples were analysed with a microbiological assay.
    Results: PLGA microspheres between the size ranges of 2.16-4.12 microm were obtained. Production yield of all formulations was found to be higher than 79% and encapsulation efficiencies of 19.8-34.3% were obtained. DSC thermogram showed that the SF was in an amorphous state in the microspheres and the glass transition temperature (T(g)) of PLGA was not influenced by the preparation procedure. In vitro drug release studies had indicated that these microspheres had significant burst release and their drug release rates were decreased upon increasing the polymer:drug ratio (p < 0.05). Based on the in vivo data, rats implanted with SF-PLGA microspheres and empty microspheres showed 1987 +/- 1196 and 55526 +/- 49086 colony forming unit of MRSA in 1 g bone samples (CFU/g), respectively (p < 0.01).
    Conclusion: The in vitro and in vivo studies had shown that the implanted SF loaded microspheres were found to be effective for the treatment of chronic osteomyelitis in an animal experimental model. Hence, these microspheres may be potentially useful in the clinical setting.
    MeSH term(s) Animals ; Calorimetry, Differential Scanning ; Chronic Disease ; Drug Carriers/administration & dosage ; Drug Carriers/chemistry ; Fusidic Acid/chemistry ; Lactic Acid/chemistry ; Male ; Methicillin Resistance/drug effects ; Microscopy, Electron, Scanning ; Microspheres ; Osteogenesis ; Osteomyelitis/diagnostic imaging ; Osteomyelitis/drug therapy ; Osteomyelitis/pathology ; Polyglycolic Acid/chemistry ; Polylactic Acid-Polyglycolic Acid Copolymer ; Polymers/chemistry ; Polyvinyl Alcohol/chemistry ; Radiography ; Rats ; Rats, Wistar ; Staphylococcus aureus/drug effects
    Chemical Substances Drug Carriers ; Polymers ; Polylactic Acid-Polyglycolic Acid Copolymer (1SIA8062RS) ; Polyglycolic Acid (26009-03-0) ; Lactic Acid (33X04XA5AT) ; Fusidic Acid (59XE10C19C) ; Polyvinyl Alcohol (9002-89-5)
    Language English
    Publishing date 2007-07-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 843632-0
    ISSN 1464-5246 ; 0265-2048
    ISSN (online) 1464-5246
    ISSN 0265-2048
    DOI 10.1080/02652040701472584
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Purely Endonasal Endoscopic Approaches for Extracranial Trigeminal Nerve Schwannoma.

    Başak, Hazan / Mulazimoglu, Selcuk / Yucel, Levent / Beton, Suha / Meco, Cem

    The Journal of craniofacial surgery

    2022  Volume 33, Issue 8, Page(s) 2473–2476

    Abstract: Objective: The aim of this study is to assess the effectiveness and safety of purely endonasal endoscopic resection of extracranial trigeminal schwannomas (TGSs), with assessment of surgical and clinical outcomes in order to identify optimal candidates ... ...

    Abstract Objective: The aim of this study is to assess the effectiveness and safety of purely endonasal endoscopic resection of extracranial trigeminal schwannomas (TGSs), with assessment of surgical and clinical outcomes in order to identify optimal candidates for an endonasal endoscopic approach (EEA).
    Methods: A retrospective review of patient's records operated for TGSs between 2008 and 2021 was conducted. Patients operated with a purely EEA were included in this study. Pictures from a frozen fresh cadaver head dissection were used to demonstrate the surgical approach and to show anatomic relationships, complexity of the surgical area and safe corridors for surgery.
    Results: A total of 5 patients (4 females and 1 male) were operated for TGS. All patients had facial numbness (100%) as a presenting symptom, followed by facial pain in 2 patients (40%), and orbital pain in 1 (20%). Also, 3 patients (60%) had a tumor originating at the level of the foramen ovale and 2 (40%) at the foramen rotundum. The mean tumor diameter was 3,7 ± 2 cm. Gross total resection were achieved in all cases. Postoperatively, 1 patient had severe mastication problems, 1 had blurred vision, and in the long-term follow-up, 1 had frontal sinusitis. The mean follow up was 106.6 (min:49, max:132, SD: 29.82) months. No recurrences were detected.
    Conclusions: In cases with the extradural TGS having limited extension into Posterior Cranial Fossa, or located in the Middle Cranial Fossa, a purely EEA is possible even for tumors bigger in size. Unilateral endonasal corridors are adequate for resection in most cases.
    MeSH term(s) Female ; Humans ; Male ; Cranial Nerve Neoplasms/surgery ; Neurilemmoma/surgery ; Neurilemmoma/pathology ; Nose/surgery ; Endoscopy ; Trigeminal Nerve/pathology
    Language English
    Publishing date 2022-06-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1159501-2
    ISSN 1536-3732 ; 1049-2275
    ISSN (online) 1536-3732
    ISSN 1049-2275
    DOI 10.1097/SCS.0000000000008687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Role of Vitamin D, ACE2 and the Proteases as TMPRSS2 and Furin on SARS-CoV-2 Pathogenesis and COVID-19 Severity.

    Ortatatli, Mesut / Fatsa, Tugba / Mulazimoglu, Deniz Dogan / Oren, Sema / Artuk, Cumhur / Hosbul, Tugrul / Kulahlioglu, Neslihan / Kenar, Levent

    Archives of medical research

    2023  Volume 54, Issue 3, Page(s) 223–230

    Abstract: Background: COVID-19, the 21: Objective: In our study, the relationship between the pathogenesis and clinical severity of COVID-19 and vitamin D, ACE2, Furin and TMPRSS2 was investigated.: Methods: Serum 25(OH)D, 1,25(OH): Results: ... ...

    Abstract Background: COVID-19, the 21
    Objective: In our study, the relationship between the pathogenesis and clinical severity of COVID-19 and vitamin D, ACE2, Furin and TMPRSS2 was investigated.
    Methods: Serum 25(OH)D, 1,25(OH)
    Results: Statistically significant differences were found between the severity of COVID-19 and all study parameters, except for serum 25(OH)D. A strong negative correlation was found between serum ACE2 protein, 1,25(OH)
    Conclusion: This study suggests that vitamin D supplementation could be beneficial in the treatment and/or prevention of COVID-19.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Furin/genetics ; Angiotensin-Converting Enzyme 2/genetics ; Peptide Hydrolases ; Vitamin D ; Leukocytes, Mononuclear/metabolism ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Serine Endopeptidases/genetics
    Chemical Substances Furin (EC 3.4.21.75) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Peptide Hydrolases (EC 3.4.-) ; Vitamin D (1406-16-2) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; TMPRSS2 protein, human (EC 3.4.21.-) ; Serine Endopeptidases (EC 3.4.21.-)
    Language English
    Publishing date 2023-02-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1156844-6
    ISSN 1873-5487 ; 0188-4409 ; 0188-0128
    ISSN (online) 1873-5487
    ISSN 0188-4409 ; 0188-0128
    DOI 10.1016/j.arcmed.2023.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT.

    Demirci, Emre / Has Simsek, Duygu / Kabasakal, Levent / Mülazimoğlu, Mehmet

    Clinical nuclear medicine

    2017  Volume 42, Issue 12, Page(s) e504–e505

    Abstract: Ga-prostate-specific membrane antigen (PSMA) PET/CT is a rapidly evolving diagnostic technique to image prostate cancer. In contrast to the name PSMA, various tissues show Ga-PSMA uptake in PET/CT imaging. We present a case of a 68-year-old man with ... ...

    Abstract Ga-prostate-specific membrane antigen (PSMA) PET/CT is a rapidly evolving diagnostic technique to image prostate cancer. In contrast to the name PSMA, various tissues show Ga-PSMA uptake in PET/CT imaging. We present a case of a 68-year-old man with prostate cancer who underwent Ga-PSMA PET/CT. Along with metastatic lymph nodes, multiple nodular lesions within the peritoneal spaces of all 4 quadrants of the abdomen showed high PSMA expression. Because of a history of splenic rupture, a Tc-labeled heat-denatured erythrocyte scintigraphy and SPECT were performed. Peritoneal lesions showed high uptake, confirming widespread peritoneal splenosis.
    MeSH term(s) Aged ; Antigens, Surface/metabolism ; Diagnosis, Differential ; Glutamate Carboxypeptidase II/metabolism ; Humans ; Male ; Peritoneal Neoplasms/diagnostic imaging ; Peritoneal Neoplasms/secondary ; Positron Emission Tomography Computed Tomography ; Prostatic Neoplasms/pathology ; Single Photon Emission Computed Tomography Computed Tomography ; Spleen/diagnostic imaging ; Splenosis/diagnostic imaging
    Chemical Substances Antigens, Surface ; FOLH1 protein, human (EC 3.4.17.21) ; Glutamate Carboxypeptidase II (EC 3.4.17.21)
    Language English
    Publishing date 2017-11-16
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 197628-x
    ISSN 1536-0229 ; 0363-9762
    ISSN (online) 1536-0229
    ISSN 0363-9762
    DOI 10.1097/RLU.0000000000001878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A prospective study: inflammation, infection and comorbidity in patients on long-term dialysis.

    Akbaş, Türkay / Mülazımoğlu, Lütfiye / Aksu, Burak / Akoğlu, Emel

    Journal of renal care

    2014  Volume 40, Issue 1, Page(s) 6–13

    Abstract: ... 3 mg/l, ESR >50 mm/hour and fibrinogen >4 g/l were, respectively, 63.1%, 60.4%, 48.6% and 42.3 ...

    Abstract Background: The goal of this study was to identify inflammatory and infectious markers and their roles in mortality.
    Methods: We enrolled 111 patients on haemodialysis (HD) and collected data at three time points (baseline, 33 and 76 months).
    Results: Rates of Chlamydophila pneumoniae IgG, CRP ≥3 mg/l, ESR >50 mm/hour and fibrinogen >4 g/l were, respectively, 63.1%, 60.4%, 48.6% and 42.3%. Mortality was 21.6% and 43.2% at 33 and 76 months where 58.3% of all deaths were cardiocerebrovascular (CCV) related. Non-survivors were older than survivors. Univariate analysis showed diabetes mellitus (DM) and cerebrovascular accident (CVA) as important for the 33-month all-cause mortality, and CRPlog , fibrinogen, ESR >50 mm/hour, cardiovascular disease (CVD) and DM for the 76-month all-cause mortality. CVA was meaningful for the 33-month CCV mortality, and CVD, DM and ESR >50 mm/hour for the 76-month CCV mortality. Kaplan-Meier revealed poorer survival for patients with ESR >50 mm/hour at 76 months. Cox regression showed CVD, CVA and age as mortality predictors.
    Conclusion: Age, CVD and CVA are predictors for mortality in patients on HD patients, but the presence of C. pneumoniae IgG and inflammation are not.
    MeSH term(s) Aged ; Antibodies, Bacterial/blood ; Biomarkers/blood ; C-Reactive Protein/metabolism ; Cardiovascular Diseases/epidemiology ; Chlamydophila Infections/epidemiology ; Chlamydophila pneumoniae/immunology ; Chlamydophila pneumoniae/isolation & purification ; Comorbidity ; Enzyme-Linked Immunosorbent Assay ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin G/blood ; Inflammation/epidemiology ; Kidney Failure, Chronic/mortality ; Kidney Failure, Chronic/therapy ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Renal Dialysis ; Risk Factors ; Stroke/epidemiology ; Survival Analysis
    Chemical Substances Antibodies, Bacterial ; Biomarkers ; Immunoglobulin G ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2014-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2375362-6
    ISSN 1755-6686 ; 1755-6678 ; 1019-083X
    ISSN (online) 1755-6686
    ISSN 1755-6678 ; 1019-083X
    DOI 10.1002/jorc.12042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.

    Sili, Uluhan / Ay, Pınar / Bilgin, Hüseyin / Topuzoğlu, Ahmet / Tükenmez-Tigen, Elif / Ertürk-Şengel, Buket / Yağçı-Çağlayık, Dilek / Balcan, Baran / Kocakaya, Derya / Olgun-Yıldızeli, Şehnaz / Gül, Fethi / Bilgili, Beliz / Can-Sarınoğlu, Rabia / Karahasan-Yağcı, Ayşegül / Mülazimoğlu-Durmuşoğlu, Lütfiye / Eryüksel, Emel / Odabaşı, Zekaver / Direskeneli, Haner / Karakurt, Sait /
    Korten, Volkan

    Infectious diseases & clinical microbiology

    2023  Volume 5, Issue 2, Page(s) 94–105

    Abstract: Objective: This study aimed to define the predictors of critical illness development within 28 days postadmission during the first wave of the COVID-19 pandemic.: Materials and methods: We conducted a prospective cohort study including 477 PCR- ... ...

    Abstract Objective: This study aimed to define the predictors of critical illness development within 28 days postadmission during the first wave of the COVID-19 pandemic.
    Materials and methods: We conducted a prospective cohort study including 477 PCR-positive COVID-19 patients admitted to a tertiary care hospital in Istanbul from March 12 to May 12, 2020.
    Results: The most common presenting symptoms were cough, dyspnea, and fatigue. Critical illness developed in 45 (9.4%; 95% CI=7.0%-12.4%) patients. In the multivariable analysis, age (hazard ratio (HR)=1.05,
    Conclusion: Age, comorbidity number, the WHO scale, LDH, and procalcitonin were independently associated with critical illness development. Mortality from COVID-19 seemed to be decreasing as the first wave of the pandemic advanced.
    Graphic abstract: Graphic Abstract.
    Language English
    Publishing date 2023-06-23
    Publishing country Turkey
    Document type Journal Article
    ISSN 2667-646X
    ISSN (online) 2667-646X
    DOI 10.36519/idcm.2023.206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Alloprevotella rava

    Ulger Toprak, N / Duman, N / Sacak, B / Ozkan, M C / Sayın, E / Mulazimoglu, L / Soyletir, G

    New microbes and new infections

    2021  Volume 42, Page(s) 100880

    Abstract: The anaerobic, Gram-negative ... ...

    Abstract The anaerobic, Gram-negative bacillus
    Language English
    Publishing date 2021-04-14
    Publishing country England
    Document type Case Reports
    ZDB-ID 2750179-6
    ISSN 2052-2975
    ISSN 2052-2975
    DOI 10.1016/j.nmni.2021.100880
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Treatment of community-acquired pneumonia in hospitalised patients.

    Mulazimoglu, L

    International journal of antimicrobial agents

    2001  Volume 18 Suppl 1, Page(s) S63–70

    Abstract: Community-acquired pneumonia (CAP) can be life-threatening. The prognosis is generally poorest in elderly patients and/or those with underlying chronic conditions, but fatalities can occur in all age groups. Current challenges in the clinical management ... ...

    Abstract Community-acquired pneumonia (CAP) can be life-threatening. The prognosis is generally poorest in elderly patients and/or those with underlying chronic conditions, but fatalities can occur in all age groups. Current challenges in the clinical management of CAP are discussed, and the criteria for identifying those patients who should be treated in hospital with initial intravenous therapy are considered. Rapid initiation of therapy is important, using an agent that provides coverage against the most likely pathogens--Streptococcus pneumoniae and the atypical organisms. There is an increasing tendency to minimise the duration of intravenous therapy, with an early transition to oral therapy and the rapid return of the patient to the community. The efficacy of oral macrolides in the treatment of CAP is well established. Evidence for the use of intravenous azithromycin to provide effective and well-tolerated, first-line intervention in the hospitalized CAP patient is summarised.
    MeSH term(s) Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/economics ; Anti-Bacterial Agents/therapeutic use ; Community-Acquired Infections/complications ; Community-Acquired Infections/drug therapy ; Community-Acquired Infections/microbiology ; Community-Acquired Infections/mortality ; Drug Interactions ; Drug Therapy, Combination ; Hospitalization ; Humans ; Injections, Intravenous ; Macrolides ; Pneumonia, Bacterial/diagnosis ; Pneumonia, Bacterial/drug therapy ; Pneumonia, Bacterial/microbiology ; Pneumonia, Bacterial/mortality ; Risk Factors
    Chemical Substances Anti-Bacterial Agents ; Macrolides
    Language English
    Publishing date 2001
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/s0924-8579(01)00400-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.

    Akbal-Dagistan, Ozlem / Sevim, Mustafa / Sen, Leyla Semiha / Basarir, Nur Sena / Culha, Meltem / Erturk, Aybige / Fael, Hanan / Kaptan, Engin / Sancar, Serap / Mulazimoglu Durmusoglu, Lutfiye / Yegen, Berrak C / Yildiz-Pekoz, Ayca

    Pharmaceutics

    2022  Volume 14, Issue 11

    Abstract: Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a high ...

    Abstract Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a high drug concentration, and a safer application with less absorption into systemic circulation, it was aimed to elucidate whether favipiravir delivered via soft-mist inhaler has any deleterious effects on lung, liver and kidney tissues of healthy rats. Wistar albino rats of both sexes (n = 72) were placed in restrainers, and were given either saline or favipiravir (1, 2.5, 5 or 10 mg/kg in 1 mL saline) by inhalation within 2 min for 5 consecutive days. On the 6th day, electrocardiographic recording was obtained, and cardiac blood and lung tissues were collected. Favipiravir did not alter cardiac rhythm, blood cell counts, serum levels of alanine transaminase, aspartate transaminase, blood urea nitrogen, creatinine, urea or uric acid, and did not cause any significant changes in the pulmonary malondialdehyde, myeloperoxidase activity or antioxidant glutathione levels. Our data revealed that pulmonary use of favipiravir via soft-mist inhaler enables a high local concentration compared to plasma without oxidative lung injury or cardiac or hepatorenal dysfunction.
    Language English
    Publishing date 2022-11-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics14112375
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.

    Bilgin, Huseyin / Marku, Marisa / Yilmaz, Sultan Seval / Karahasan Yagci, Aysegul / Sili, Uluhan / Can, Baris / Can Sarinoglu, Rabia / Mulazimoglu Durmusoglu, Lutfiye / Haklar, Goncagul / Sirikci, Onder / Eksioglu Demiralp, Emel

    Vaccine

    2022  Volume 40, Issue 18, Page(s) 2619–2625

    Abstract: Objectives: We evaluated the antibody response, natural killer cell response and B cell phenotypes in healthcare workers (HCW) who are vaccinated with two doses of CoronaVac with or without documented SARS-CoV-2 infection and unvaccinated HCWs with SARS- ...

    Abstract Objectives: We evaluated the antibody response, natural killer cell response and B cell phenotypes in healthcare workers (HCW) who are vaccinated with two doses of CoronaVac with or without documented SARS-CoV-2 infection and unvaccinated HCWs with SARS-CoV-2 infection.
    Methods: HCWs were divided into four groups: vaccine only (VO), vaccine after SARS-CoV-2 infection (VAI), SARS-CoV-2 infection only (IO), and SARS-CoV-2 infection after vaccine (IAV). Anti-SARS-CoV-2 spike protein (Anti-S) antibodies were measured by Elecsys Anti-SARS-CoV-2 S ELISA kit. Memory B cells (CD19
    Results: The Anti-S antibodies were detectable in all HCWs (n: 224). The median Anti-S titers (BAU/mL) was significantly higher in VAI (620 25-75% 373-1341) compared to VO (136, 25-75% 85-283) and IO (111, 25-75% 54-413, p < 0.01). VAI group had significantly lower percentage of plasmablasts (2.9; 0-8.7) compared to VO (6.8; 3.5-12.0) and IO (9.9; 4.7-47.5, p < 0.01) (n:74). Percentage of LLPCs in groups VO, VAI and IO was similar. There was no difference of IFN-γ levels between the study groups (n: 76).
    Conclusion: The antibody response was similar between uninfected vaccinated HCWs and unvaccinated HCWs who had natural infection. HCWs who had two doses of CoronaVac either before or after the natural SARS-CoV-2 infection elicited significantly higher antibody responses compared to uninfected vaccinated HCWs. The lower percentages of plasmablasts in the VAI group may indicate their migration to lymph nodes and initiation of the germinal center reaction phase. IFN-γ response did not differ among the groups.
    MeSH term(s) Antibodies, Viral ; COVID-19/prevention & control ; COVID-19 Vaccines ; Humans ; Interferon-gamma ; Killer Cells, Natural ; Plasma Cells ; SARS-CoV-2 ; Vaccination
    Chemical Substances Antibodies, Viral ; COVID-19 Vaccines ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2022-03-18
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2022.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top